Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Mol Neurobiol ; 56(8): 5815-5834, 2019 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-30684218

RESUMO

Current evidence suggests dementia and pathology in Alzheimer's Disease (AD) are both dependent and independent of amyloid processing and can be induced by multiple 'hits' on vital neuronal functions. Type 2 diabetes (T2D) poses the most important risk factor for developing AD after ageing and dysfunctional IR/PI3K/Akt signalling is a major contributor in both diseases. We developed a model of T2D, coupling subdiabetogenic doses of streptozotocin (STZ) with a human junk food (HJF) diet to more closely mimic the human condition. Over 35 weeks, this induced classic signs of T2D (hyperglycemia and insulin dysfunction) and a modest, but stable deficit in spatial recognition memory, with very little long-term modification of proteins in or associated with IR/PI3K/Akt signalling in CA1 of the hippocampus. Intracerebroventricular infusion of soluble amyloid beta 42 (Aß42) to mimic the early preclinical rise in Aß alone induced a more severe, but short-lasting deficits in memory and deregulation of proteins. Infusion of Aß on the T2D phenotype exacerbated and prolonged the memory deficits over approximately 4 months, and induced more severe aberrant regulation of proteins associated with autophagy, inflammation and glucose uptake from the periphery. A mild form of environmental enrichment transiently rescued memory deficits and could reverse the regulation of some, but not all protein changes. Together, these data identify mechanisms by which T2D could create a modest dysfunctional neuronal milieu via multiple and parallel inputs that permits the development of pathological events identified in AD and memory deficits when Aß levels are transiently effective in the brain.


Assuntos
Doença de Alzheimer/epidemiologia , Doença de Alzheimer/etiologia , Diabetes Mellitus Tipo 2/complicações , Doença de Alzheimer/sangue , Doença de Alzheimer/fisiopatologia , Peptídeos beta-Amiloides/administração & dosagem , Animais , Glicemia/metabolismo , Diabetes Mellitus Tipo 2/sangue , Comportamento Alimentar , Hipocampo/patologia , Hipocampo/ultraestrutura , Humanos , Insulina/sangue , Masculino , Memória , Transtornos da Memória/complicações , Modelos Biológicos , Fosforilação , Ratos Sprague-Dawley , Fatores de Risco , Estreptozocina , Aumento de Peso
2.
J Environ Sci Health B ; 52(5): 314-325, 2017 May 04.
Artigo em Inglês | MEDLINE | ID: mdl-28277086

RESUMO

In this study, a three-factor, three-level Box-Behnken design with response surface methodology were used to maximize the TOC removal and minimize the H2O2 residual in the effluent of the combined UV-C/H2O2-VUV system for the treatment of an actual slaughterhouse wastewater (SWW) collected from one of the meat processing plants in Ontario, Canada. The irradiation time and the initial concentrations of total organic carbon (TOCo) and hydrogen peroxide (H2O2o) were the three predictors, as independent variables, studied in the design of experiments. The multiple response approach was used to obtain desirability response surfaces at the optimum factor settings. Subsequently, the optimum conditions to achieve the maximum percentage TOC removal of 46.19% and minimum H2O2 residual of 1.05% were TOCo of 213 mg L-1, H2O2o of 450 mg L-1, and irradiation time of 9 min. The attained optimal operating conditions were validated with a complementary test. Consequently, the TOC removal of 45.68% and H2O2 residual of 1.03% were achieved experimentally, confirming the statistical model reliability. Three individual processes, VUV alone, VUV/H2O2, and UV-C/H2O2, were also evaluated to compare their performance for the treatment of the actual SWW using the optimum parameters obtained in combined UV-C/H2O2-VUV processes. Results confirmed that an adequate combination of the UV-C/H2O2-VUV processes is essential for an optimized TOC removal and H2O2 residual. Finally, respirometry analyses were also performed to evaluate the biodegradability of the SWW and the BOD removal efficiency of the combined UV-C/H2O2-VUV processes.


Assuntos
Peróxido de Hidrogênio/química , Eliminação de Resíduos Líquidos/métodos , Matadouros , Biodegradação Ambiental , Carbono/análise , Peróxido de Hidrogênio/análise , Oxirredução , Fotobiorreatores , Reprodutibilidade dos Testes , Raios Ultravioleta , Eliminação de Resíduos Líquidos/instrumentação , Águas Residuárias/química
3.
Pediatr Diabetes ; 18(3): 178-187, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-27174469

RESUMO

Genome-wide association studies (GWAS) have identified more than 40 T1D loci associated with type 1 diabetes (T1D). How these polymorphisms interact with environmental factors to trigger T1D is unknown, but recent evidence suggests that epigenetic mechanisms could play a role. To begin to explore the contribution of epigenetics to T1D, we have examined DNA methylation in a pilot study of whole blood cells DNA from 10 young T1D patients and 10 young controls. Through the study of >900 000 CG loci across a diverse set of functionally relevant genomic regions using a custom DNA methylation array, we identified 250 T1D-differentially methylated region (DMR) at p < 0.05 and 1 DMR using next a permutation-based multiple testing correction method. This DMR is located in an imprinted region previously associated with T1D on the chromosome 14 that encompasses RTL1 gene and 2 miRNAs (miR136 and miR432). Using pyrosequencing-based bisulfite PCR, we replicated this association in a different and larger set of T1D patients and controls. DNA methylation at this DMR was inversely correlated with RTL1 gene expression and positively correlated with miR136 expression in human placentas. The DMR identified in this study presents suggestive evidence for altered methylation site in T1D and provide a promising new candidate gene. RTL1 is essential for placental permeability function in the mid-to-late fetal stages. We suggest that hypo-methylation could increase the fetal exposure to environmental factors in T1D susceptibility.


Assuntos
Desmetilação do DNA , Diabetes Mellitus Tipo 1/metabolismo , Regulação da Expressão Gênica no Desenvolvimento , Loci Gênicos , MicroRNAs/metabolismo , Proteínas da Gravidez/metabolismo , Regiões Promotoras Genéticas , Adulto , Células Sanguíneas/metabolismo , Criança , Estudos de Coortes , Diabetes Mellitus Tipo 1/sangue , Diabetes Mellitus Tipo 1/genética , Epigênese Genética , Feminino , Humanos , Masculino , Projetos Piloto , Placenta/metabolismo , Gravidez , Proteínas da Gravidez/genética , Estudos Prospectivos , Bancos de Tecidos
4.
Mol Biochem Parasitol ; 176(2): 127-30, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21232559

RESUMO

RNA polymerase II is an essential nuclear multi subunit enzyme that transcribes nearly the whole genome. Its inhibition by the alpha-amanitin toxin leads to cell death. The enzyme of Plasmodium falciparum remains poorly characterized. Using a complementation assay in yeast as a genetic test, we demonstrate that five Plasmodium putative RNA polymerase subunits are indeed functional in vivo. The active site of this enzyme is built from the two largest subunits. Using site directed mutagenesis we were able to modify the active site of the yeast RNA polymerase II so as to introduce Plasmodium or human structural motifs. The resulting strains allow the screening of chemical libraries for potential specific inhibitors.


Assuntos
Plasmodium falciparum/genética , Subunidades Proteicas/genética , Proteínas de Protozoários/genética , RNA Polimerase II/genética , Proteínas Recombinantes/genética , Saccharomyces cerevisiae/genética , Alfa-Amanitina/farmacologia , Motivos de Aminoácidos , Sequência de Aminoácidos , Domínio Catalítico , Inibidores Enzimáticos/farmacologia , Teste de Complementação Genética , Humanos , Malária Falciparum/parasitologia , Dados de Sequência Molecular , Mutagênese Sítio-Dirigida , Plasmodium falciparum/efeitos dos fármacos , Plasmodium falciparum/metabolismo , Subunidades Proteicas/metabolismo , Proteínas de Protozoários/metabolismo , RNA Polimerase II/metabolismo , Proteínas Recombinantes/metabolismo , Saccharomyces cerevisiae/metabolismo , Homologia de Sequência de Aminoácidos , Bibliotecas de Moléculas Pequenas , Transcrição Gênica/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...